Results 81 to 90 of about 17,861,189 (258)

Peer effects in health valuation: the relation between rating of contemporaries’ health and own health

Health and Quality of Life Outcomes, 2018
Background Most health valuation studies assume that individuals’ health valuations do not depend on social comparisons. However, there is some evidence that this assumption is not satisfied in practice.
Arthur E. Attema, Werner B. F. Brouwer, Jose Luis Pinto Prades   +2 more
doaj   +1 more source

Adjusted quality of life for cancer survivors.

, 2016
Adjusted quality of life for cancer survivors.
Mei Kang (2610154), Qinglong Deng (2610151), Jinming Yu (652099), Jiwei Wang (508674), Zheng Tang (1297200), Furong Tang (2610157)   +5 more
core   +1 more source

Lifetime societal costs and quality-adjusted life years.

, 2023
Lifetime societal costs and quality-adjusted life years.
Marianne Hamilton Lopez (15314696), Joanne Kurtzberg (832027), Evan Myers (353856), Beth Shaz (15314699), Ethan D. Borre (6890177), Jesse Troy (15314702), Gillian D. Sanders Schmidler (15314705)   +6 more
core   +1 more source

Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells

Molecular Oncology, EarlyView.
We established the avian chorioallantoic membrane (CAM) assay as a scalable in vivo model for studying circulating tumor cells (CTCs). Human gastrointestinal tumors spontaneously released genetically validated CTCs that were detected across multiple platforms, demonstrating that the CAM model provides an accessible tool for investigating early cancer ...
Dennis Roth, Rui P. L. Neves, Julia Geheb, Christian Ballmeyer, Nathalie Gaßmann, Kiki C. Andree, Monica Sudarsanam, Christiane Driemel, Celine Örencik, Andrè Franken, Eslam Elmaghraby, Sven H. Loosen, Roderburg Christoph, Sebastian Schoelch, Hans Neubauer, Wolfram T. Knoefel, Nikolas H. Stoecklein, Georg Fluegen   +17 more
wiley   +1 more source

Justifying Terminal Care by 'Retrospective Quality-Adjusted Life-Years'

, 2010
A lot of medical procedures can be justified in terms of the number of quality-adjusted life-years (QALYs) they can be expected to generate; that is, the number of extra years that the procedure will provide, with the quality of life during those extra ...
Cowley, Christopher
core   +1 more source

Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer

Molecular Oncology, EarlyView.
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau, Daniel Pincher, Clifford Young, Nicholas Chappell, Noor A. Lokman, Parul Mittal, Leigh Donnellan, Martin K. Oehler, Doug A. Brooks, Peter Hoffmann   +9 more
wiley   +1 more source

Measuring health and subjective wellbeing: vale, quality-adjusted life-years

, 2005
Measuring health and subjective wellbeing: vale, quality-adjusted life ...
Robert Cummins (13065627)
core  

Reporting methods for eliciting health preference in relation to estimating willingness to pay per quality-adjusted life year.

Reporting methods for eliciting health preference in relation to estimating willingness to pay per quality-adjusted life year.
Klas Göran Sahlen (17935584), Lars Lindholm (21685), Anh Nu Vu (17935581), Minh Van Hoang (6842081), Cuc Thi Thu Nguyen (14059662), Sun Sun (15469762)   +5 more
core   +1 more source

GelMA‐based 3D spheroids recapitulate transcriptomic and functional hallmarks of myeloid sarcoma

FEBS Open Bio, EarlyView.
GelMA 5% hydrogels support the formation of myeloid leukemia spheroids that recapitulate MS‐specific features, including G1 arrest, apoptosis, and ECM‐driven transcriptomic reprogramming. The 3D model mimicked soft‐tissue‐like stiffness and oxygen conditions, and transcriptomic convergence with primary MS samples confirmed its utility as a preclinical ...
Nicolas Germain, Elise Buret, Le Hoang Thanh Nguyen, Marion Cocheteux, Nicolas Touya, Mélanie Dhayer, Romain Dubois, Frank Lafont, Sebastien Janel, Patrice Maboudou, Steve Lancel, Philippe Marchetti   +11 more
wiley   +1 more source

Long‐term cost‐effectiveness of transcatheter mitral valve repair in  HF patients with secondary mitral regurgitation

ESC Heart Failure
Aims The long‐term cost‐effectiveness of MitraClip in heart failure patients with secondary mitral regurgitation is still unclear. This study aimed to evaluate the long‐term cost‐effectiveness of MitraClip added to guideline‐directed medical therapy vs ...
Younan Yao, Ziyou Zhou, Tian Geng, Anping Cai, Tian Li, Junqing Yang, Jiyan Chen, Liwen Li   +7 more
doaj   +1 more source